ALLO - Allogene: Cutting Edge Allogeneic CAR-T Therapy Developer December, 16 2020 12:46 PM Allogene Therapeutics Inc. Allogene is a leader in its space, allogeneic CAR-T targeting mainly hematologic malignancies. The company is flush with cash. If successful, this company could be a major winner. For further details see: Allogene: Cutting Edge Allogeneic CAR-T Therapy Developer